PRESS RELEASE published on 05/09/2023 at 07:30, 3 years 5 months ago APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills
PRESS RELEASE published on 05/08/2023 at 07:30, 3 years 5 months ago APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development partnership with Zentiva Group for another Single Pill with EU-wide intellectual property rights
PRESS RELEASE published on 05/03/2023 at 13:00, 3 years 5 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Bioleaching Potential for the W4 Nickel Sulphides
PRESS RELEASE published on 05/02/2023 at 21:50, 3 years 5 months ago EQS-Adhoc: APONTIS PHARMA AG adjusts forecast for fiscal year 2023
PRESS RELEASE published on 04/27/2023 at 07:30, 3 years 5 months ago APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary prophylaxis of cardiovascular events - market launch already planned for early 2024
PRESS RELEASE published on 04/20/2023 at 13:00, 3 years 5 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Carbon Capture and Storage ("CCS") Potential of the CarLang Area
PRESS RELEASE published on 04/12/2023 at 13:00, 3 years 6 months ago EV Nickel Announces Filing of NI 43-101 Technical Report for Previously Announced CarLang Project Maiden Resource
PRESS RELEASE published on 04/12/2023 at 07:30, 3 years 6 months ago APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential
PRESS RELEASE published on 03/28/2023 at 13:00, 3 years 6 months ago EV Nickel Continues to Expand the High-Grade W4 Zone with Impressive Nickel Drill Hole Intercepts Including 13.1m Grading 1.47% Ni and 2.1m Grading 3.01% Ni
PRESS RELEASE published on 03/09/2023 at 07:30, 3 years 7 months ago APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations
Published on 10/13/2026 at 17:15, 29 minutes ago Caldwell Names John Staines as Partner and Leader of Global HR Practice
Published on 10/13/2026 at 15:00, 2 hours 44 minutes ago Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Published on 10/13/2026 at 14:45, 2 hours 59 minutes ago Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
Published on 10/13/2026 at 14:31, 3 hours 13 minutes ago First Breach Completes First Autonomous Flight of Proprietary Drone Prototype
Published on 10/13/2026 at 14:10, 3 hours 34 minutes ago NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 16:15, 1 hour 29 minutes ago CGTN: A Mountain Road That Transformed a Village
Published on 10/13/2026 at 15:10, 2 hours 34 minutes ago CurTec expands US manufacturing and warehouse capacity in Westminster, S.C.
Published on 10/13/2026 at 15:06, 2 hours 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/13/2026 at 15:05, 2 hours 39 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/13/2026 at 15:05, 2 hours 39 minutes ago Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats
Published on 10/13/2026 at 09:04, 8 hours 39 minutes ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 23 hours 44 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 23 hours 59 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 1 day 1 hour ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
